Evidence map›Paper›PMID 32411000›Full record

ArticleFrontiers in pharmacology2020

Model-Informed Precision Dosing of Vancomycin in Hospitalized Children: Implementation and Adoption at an Academic Children's Hospital.

Adam Frymoyer, Hayden T Schwenk, Yvonne Zorn, Laura Bio, Jeffrey D Moss, Bhavin Chasmawala, Joshua Faulkenberry, Srijib Goswami, Ron J Keizer, Shabnam Ghaskari

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 7 pooled it
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 7 syntheses or guidelines pooled it, 74 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Population Pharmacokinetics of Amikacin in Non-Neonatal Pediatric Patients: A Scoping Review.European journal of drug metabolism and pharmacokinetics · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. State of Vancomycin Dosing in Neonates: An Overview.The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2026
    Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Adam FrymoyerDepartment of Pediatrics, Stanford University School of Medicine, Palo Alto, CA, United States.
Hayden T SchwenkDepartment of Pediatrics, Stanford University School of Medicine, Palo Alto, CA, United States.
Yvonne ZornDepartment of Clinical Pharmacy, Lucile Packard Children's Hospital Stanford, Palo Alto, CA, United States.
Laura BioDepartment of Clinical Pharmacy, Lucile Packard Children's Hospital Stanford, Palo Alto, CA, United States.
Jeffrey D MossDepartment of Clinical Pharmacy, Lucile Packard Children's Hospital Stanford, Palo Alto, CA, United States.
Bhavin ChasmawalaInformation Services, Lucile Packard Children's Hospital Stanford, Palo Alto, CA, United States.
Joshua FaulkenberryInformation Services, Lucile Packard Children's Hospital Stanford, Palo Alto, CA, United States.
Srijib GoswamiInsightRx, San Francisco, CA, United States.
Ron J KeizerInsightRx, San Francisco, CA, United States.
Shabnam GhaskariInformation Services, Lucile Packard Children's Hospital Stanford, Palo Alto, CA, United States.
Lucile Packard Children's Hospital · USStanford University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundModel-informed precision dosing (MIPD) can serve as a powerful tool during therapeutic drug monitoring (TDM) to help individualize dosing in populations with large pharmacokinetic variation. Yet, adoption of MIPD in the clinical setting has been limited. Overcoming technologic hurdles that allow access to MIPD at the point-of-care and placing it in the hands of clinical specialists focused on medication dosing may encourage adoption.

objectiveTo describe the hospital implementation and usage of a MIPD clinical decision support (CDS) tool for vancomycin in a pediatric population.

methodsWithin an academic children's hospital, MIPD for vancomycin was implemented

resultsAfter a successful pilot phase in the neonatal intensive care unit, implementation of MIPD was expanded to the pediatric intensive care unit, followed by availability to the entire hospital. During the first 2+ years since implementation, a total of 853 patient-courses (n = 96 neonates, n = 757 children) and 2,148 TDM levels were evaluated using the CDS tool. For the most recent 6 months, the CDS tool was utilized to support 79% (181/230) of patient-courses in which TDM was performed. Of 26 users surveyed, > 96% agreed or strongly agreed that automatic transmission of patient data to the tool was a feature that helped them complete tasks more efficiently; 81% agreed or strongly agreed that they were satisfied with the CDS tool.

conclusionsIntegration of a vancomycin CDS tool within the EHR, along with leveraging the expertise of clinical pharmacists, allowed for successful adoption of MIPD in clinical care.

Indexed as

childrenclinical decision supportpharmacokineticstherapeutic drug monitoringvancomycin

Identifiers

PMID32411000
PMCPMC7201037
OpenAlexW3022898494

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.